IL10RA and inflammatory bowel disease: To confirm their increased predisposition to develop intestinal pathology, we used an experimental model of IBD triggered by infection with Helicobacter hepaticus and concomitant treatment with anti-IL-10R mAbs (Song-Zhao and Maloy, 2014).